BPsyDAO is a decentralized biotech protocol that creates a marketplace for research and an IP NFT framework. It funds biotech projects—particularly in cryopreservation—by offering up to $100,000 per project and connecting academics, biotech companies, investors, and patients in a fully governance-driven community. Powered by Molecule, PsyDAO reviews applications for new cohorts and supports DAO founders with a network of experienced contributors, enabling direct ownership and control of research IP through IP NFTs. Unlike traditional funding models, PsyDAO blends DeSci principles with an open-source ethos, allowing patients, researchers, and investors to govern and benefit from research outcomes. Its goal is to accelerate biotech research by providing rapid, community-governed funding and a novel IP framework that unlocks data access and legal rights for research.
Work here?Claim your company
Industries
Company Size
11-50
Company Stage
Seed
Total Funding
$71.3M
Headquarters
Nantes, France
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$71.3M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Bio Protocol CEO announced his team used AI to design a novel ADHD drug candidate in roughly 24 hours. The AI scientist, PeptAI, ran simulated testing and priced initial physical lab validation at $1,000 to $1,500, compared to millions and years in traditional pharma. This cost collapse enables decentralised science (DeSci) funding models to support research through entire discovery phases. Bio Protocol, a token-governed platform routing capital to research DAOs, has become central to this shift by combining community funding with "agentic science". The company released BIOS in January, an AI scientist coordinating specialised agents for literature search and computational analysis. However, Bio Protocol acknowledges three structural problems remain on the path from candidate to approved drug, even with AI-enabled discovery and community fundraising combined.
Bio Protocol is set to roll out dValueChain v.1.0 in the first quarter.
Bio Protocol secured $6.9 million in funding from Maelstrom Fund, Animoca Brands and other investors to advance science using AI and crypto.
Bio Protocol has secured $7 million in seed funding, led by Arthur Hayes' Maelstrom Fund. The decentralized science protocol aims to develop "scientific superintelligence" onchain using BioAgents.
Academic research is challenging. Obtaining grants and financial support for research projects is highly competitive and time-consuming. Researchers typically juggle multiple projects, including teaching, and they also have to deal with realities like data management and ethics.But now, a movement called Decentralised Science (DeSci) aims to transform traditional scientific research by connecting patients, scientists, investors, biotech DAOs, and novel crowdfunding methods. It democratises access to research funding through greater transparency, open access, and collaborative efforts, thus accelerating scientific breakthroughs.DeSci leverages blockchain-based platforms, tools, NFTs, tokens, decentralised autonomous organisations (DAOs), and Web3 principles to facilitate funding for scientific research.From online communities to open source bioscienceI spoke to a pioneer of the DeSci movement, Paul Kohlhaas, founder and Chief Architect at Molecule, a platform dedicated to accelerating scientific research and bringing intellectual property onchain through community-driven initiatives. It's like crowdfunding on steroids, where instead of getting an item in exchange for your funding, you get a cut of the intellectual property (IP).Kohlhaas spent his youth engaging with online biohacking forums and patient communities on platforms like Reddit, where online communities focused on tackling medical challenges—like diabetic patients collaborating to develop their own insulin due to its prohibitive cost in the US. From HIV communities exploring gene therapies to cancer patient groups sharing experimental treatments, nootropics and longevity, there was a community for virtually everything.He recalls:"What struck me was the collaborative and open spirit of these groups
Find jobs on Simplify and start your career today
We update Bio Protocol's jobs every few hours, so check again soon!Browse all jobs
Industries
Company Size
11-50
Company Stage
Seed
Total Funding
$71.3M
Headquarters
Nantes, France
Founded
2022
Find jobs on Simplify and start your career today
We update Bio Protocol's jobs every few hours, so check again soon!Browse all jobs